Patented Products 
  Oncology Formulations
 Therapeutic
    Segments
 Oncology API
  Specialty API's
  Chiral intermediates
 
Oncology Formulations 
KLab is one of the pioneers in India in KLAB is a pioneer in the Indian Oncology formulations market. It has one of the widest range of Oncology formulations, which are manufactured at KLAB owned WHO-GMP approved facility at Thane, Mumbai.
 
KLAB manufactures tablets, capsules, powder and liquid injectables.
KLAB's oncology products are now registered in more than 30 countries in Africa, Latin America, CIS and South East Asia. In India KLAB has a dedicated Oncology task force which covers Oncologists and Oncology Institutions across the length and breadth of India. Further, KLAB supplies finished ONCO formulations to a large number of Indian Companies.
 
 

Present

Introduced Patented Products based on NDDS
(Marketed in India and out-Licensed for the Developing Countries)

  

Future

Patents driven by NDDS, Nano and Dendrimers
(To be marketed in India and to be out Licensed to the developed countries)

 
ONCOLOGY PRODUCTS
HEMATOLOGY PRODUCTS
  • BLEOCIN
    ACTIVE INGREDIENT:BLEOMYCIN
    STRENGTH:15 UNITS
    DOSAGE FORM:LYOPHILIZED POWDER
    PRESENTATION: VIAL
 
  • BORTEMIB
    ACTIVE INGREDIENT:BORTEZOMIB
    STRENGTH:2 MG
    DOSAGE FORM:LYOPHILIZED POWDER
    PRESENTATION: VIAL
 
  • DOXORUBIN
    ACTIVE INGREDIENT:DOXORUBICIN
    STRENGTH:1O MG & 50MG
    DOSAGE FORM:LYOPHILIZED POWDER
    PRESENTATION: VIAL
 
  • IMATINATE
    ACTIVE INGREDIENT:IMATINIB
    STRENGTH:1OOMG & 400MG
    DOSAGE :CAPSULES IN A PLASTIC BOTTLE
    PRESENTATION: 1 BOTTLE WITH 10 CAPSULES
 
  • RIBOREA
    ACTIVE INGREDIENT:HYDROXYUREA
    STRENGTH:500MG
    DOSAGE FORM:CAPSULES
    PRESENTATION: 1 BOX OF 10 X 10 CAPSULES
 
  • XOLNIC
    ACTIVE INGREDIENT:ZOLEDRONIC ACID
    STRENGTH:4 MG
    DOSAGE FORM:LYOPHILIZED POWDER
    PRESENTATION: VIAL

 
SOLID TUMOR PRODUCTS
  • CAPXCEL
    ACTIVE INGREDIENT:CAPECITABINE
    STRENGTH:500MG
    DOSAGE FORM:TABLETS
    PRESENTATION: 1 STRIP OF 10 TABLETS

 
  • DOCETAXEL
    ACTIVE INGREDIENT:DOCETAXEL
    STRENGTH:20 MG & 80 MG
    DOSAGE FORM:INJECTION
    PRESENTATION: VIAL
 
  • ERLOTAZ
    ACTIVE INGREDIENT:ERLOTINIB
    STRENGTH:100MG & 150 MG
    DOSAGE FORM:TABLETS IN PLASTIC BOTTLES
    PRESENTATION: 1 BOTTLE CONTAINS 10 TABLETS
 
  • GEFTIN
    ACTIVE INGREDIENT:GEFITINIB
    STRENGTH:250MG
    DOSAGE FORM:TABLETS
    PRESENTATION: 1 STRIP CONTAINS 10 TABLETS
 
  • GEMPOWER
    ACTIVE INGREDIENT:GEMCITABINE
    STRENGTH:200MG & 1000MG
    DOSAGE FORM:LYOPHILIZED POWDER
    PRESENTATION: VIAL
 
  • KANSURE
    ACTIVE INGREDIENT:PACLITAXEL
    STRENGTH:30MG,100MG & 260MG
    DOSAGE FORM:INJECTION
    PRESENTATION: VIAL
 
  • KUCIL
    ACTIVE INGREDIENT:FLUOROURACIL
    STRENGTH:250 & 500MG
    DOSAGE FORM:AMPOULES
    PRESENTATION: 1 BOX CONTAINS 5 AMPOULES
 
  • LASTET
    ACTIVE INGREDIENT:ETOPOSIDE
    STRENGTH:50MG & 100MG
    DOSAGE FORM:CAPSULES & INJECTION
    PRESENTATION: CAPSULES IN BOTTLE & INJECTION IN VIAL
 
  • MAMAZOL
    ACTIVE INGREDIENT:LETROZOLE
    STRENGTH:2.5MG
    DOSAGE FORM:TABLETS
    PRESENTATION: 1 STRIP OF 10 TABLETS

 
  • MAMOFEN
    ACTIVE INGREDIENT:TAMOXIFEN
    STRENGTH:10 MG & 20MG
    DOSAGE FORM:TABLETS
    PRESENTATION: 1 BOX OF 10 X 10 TABLETS
 
  • PEMXCEL
    ACTIVE INGREDIENT:PEMETREXED
    STRENGTH:1OOMG & 500MG
    DOSAGE FORM:LYOPHILIZED POWDER
    PRESENTATION: VIAL
 
  • PLASTOMET
    ACTIVE INGREDIENT:METHOTREXATE
    STRENGTH:50MG/2ML
    DOSAGE FORM:INJECTION
    PRESENTATION: VIAL
 
  • PLATINEX
    ACTIVE INGREDIENT:CISPLATIN
    STRENGTH:10MG & 50MG
    DOSAGE FORM:INJECTION
    PRESENTATION: VIAL
 
  • TEMOZOL
    ACTIVE INGREDIENT:TEMOZOLOMIDE
    STRENGTH:20MG,100MG & 250MG
    DOSAGE FORM:CAPSULES
    PRESENTATION: 1 BOTTLE OF 5 CAPSULES
 
  • WOMASTIN
    ACTIVE INGREDIENT:CARBOPLATIN
    STRENGTH:15OMG & 450MG
    DOSAGE FORM:INJECTION
    PRESENTATION: VIAL
 
  • WOMAZOL
    ACTIVE INGREDIENT:ANASTROZOLE
    STRENGTH:1 MG
    DOSAGE FORM:TABLET
    PRESENTATION: 1 X 10 TABLETS
 
  • XALIPAT
    ACTIVE INGREDIENT:OXALIPLATIN
    STRENGTH:50 MG & 100MG
    DOSAGE FORM:INJECTION
    PRESENTATION: VIAL
 
     
© 2001 - 2007 Khandelwal Laboratories Pvt.Ltd. All rights reserved.